[1] Morens DM, Folkers GK, Fauci AS. The challenge of emerging and re-emerging infectious diseases. Nature , 2004, 430(6996): 242-249.
[2] Wise R. Antimicrobial resistance: priorities for action. J Antimicrob Chemother , 2002, 49(4): 585-586.
[3] Monroe S, Polk R. Antimicrobial use and bacterial resistance. Curr Opin Microbiol , 2000, 3(5): 496-501.
[4] Livermore DM. The need for new antibiotics. Clin Microbiol Infect , 2004, 10(Suppl. 4): 1-9.
[5] Andersson DI, Hughes D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol , 2010, 8(4): 260-271.
[6] Spratt BG. Resistance to antibiotics mediated by target alterations. Science , 1994, 264(5157): 388-393.
[7] Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet , 2001, 358(9276): 135-138.
[8] Barbier F, Wolff M. Multi-drug resistant Pseudomonas aeruginosa : towards a therapeutic dead end? Med Sci ( Paris ), 2010, 26(11): 960-968.
[9] Fuqua C, Greenberg EP. Listening in on bacteria: acyl- homoserine lactone signalling. Nat Rev Mol Cell Biol , 2002, 3(9): 685-695.
[10] Deng YY, Wu JE, Tao F, Zhang LH. Listening to a new language: DSF-based quorum sensing in gram-negative bacteria. Chem Rev , 2011, 111(1): 160-173.
[11] Walsh C. Molecular mechanisms that confer antibacterial drug resistance. Nature , 2000, 406(6797): 775-781.
[12] Zhou JN, Zhang HB, Lv MF, Chen YF, Liao LS, Cheng YY, Liu SY, Chen SH, He F, Cui ZN, Jiang ZD, Chang CQ, Zhang LH. SlyA regulates phytotoxin production and virulence in Dickeya zeae EC1. Mol Plant Pathol , 2016, doi:
10.1111/mpp.12376.
[13] Ambler RP, Coulson AFW, Frère JM, Ghuysen JM, Joris B, Forsman M, Levesque RC, Tiraby G, Waley SG. A standard numbering scheme for the class A β -lactamases. Biochem J , 1991, 276(1): 269-270.
[14] Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother , 1995, 39(6): 1211-1233.
[15] Medeiros A A. β-lactamases. Br Med Bull , 1984, 40(1): 18-27.
[16] Philippon A, Labia R, Jacoby G. Extended-spectrum β-lactamases. Antimicrob Agents Chemother , 1989, 33(8): 1131-1136.
[17] Ramirez MS, Tolmasky ME. Aminoglycoside modifying enzymes. Drug Resist Updat , 2010, 13(6): 151-171.
[18] Levy SB. Active efflux mechanisms for antimicrobial resistance. Antimicrob Agents Chemother , 1992, 36(4): 695-703.
[19] Paulsen IT, Brown MH, Skurray RA. Proton-dependent multidrug efflux systems. Microbiol Mol Biol Rev , 1996, 60(4): 575-608.
[20] Tipper DJ, Strominger JL. Mechanism of action of penicillins: a proposal based on their structural similarity to acyl-D-alanyl-D-alanine. Proc Natl Acad Sci USA , 1965, 54(4): 1133-1141.
[21] Song MD, Wachi M, Doi M, Ishino F, Matsuhashi M. Evolution of an inducible penicillin-target protein in methicillin-resistant Staphylococcus aureus by gene fusion. FEBS Lett , 1987, 221(1): 167-171.
[22] Ubukata K, Nonoguchi R, Matsuhashi M, Konno M. Expression and inducibility in Staphylococcus aureus of the mecA gene, which encodes a methicillin-resistant S . aureus -specific penicillin-binding protein. J Bacteriol , 1989, 171(5): 2882-2885.
[23] Peacock SJ, Paterson GK. Mechanisms of methicillin resistance in Staphylococcus aureus . Annu Rev Biochem , 2015, 84(1): 577-601.
[24] Lim D, Strynadka NCJ. Structural basis for the β lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus . Nat Struct Biol , 2002, 9(11): 870-876.
[25] Mah TFC, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol , 2001, 9(1): 34-39.
[26] Poole K. Efflux-mediated multiresistance in Gram-negative bacteria. Clin Microbiol Infect , 2004, 10(1): 12-26.
[27] de la Cruz F, Davies J. Horizontal gene transfer and the origin of spec
